Medication info

SD1-4 weeks

Prescription medicationIntravenous injection
Ingredient · strength
Glucose›40g / 1000mLSodium Chloride›1.8g / 1000mL
Manufacturer / importer
JW Crea Pharmaceuticals Co., Ltd.
Appearance
A colorless, transparent liquid contained in a polypropylene, multi-layer film plastic container.
Packaging
500 milliliters/bag, 1000 milliliters/bag
Approval status
Active

MFDS item code 197000013 · Notified 1970.10.30 · Insurance code 644901522,644901530

Summary

Main use
Replenishment of fluids and electrolytes (for dehydration and before or after surgery); improvement of dehydration by providing energy
Who receives it
Adults · Children
Adult administration
The usual dose for adults is 500~1,000mL per dose by intravenous drip infusion. The infusion rate is 300~500mL per hour (75~120 drops per minute). Adjust the dose and infusion rate as appropriate according to age, body weight, and symptoms.
Child administration
For children, administer at a rate of 50~100mL per hour. Do not administer rapidly (at a rate of 100mL or more per hour), especially to newborns and premature infants.

Ingredients

Manufacturer
JW Crea Pharmaceuticals Co., Ltd.

Efficacy & effects

Replenishment of fluids and electrolytes (for dehydration and before or after surgery); improvement of dehydration by providing energy

  • Dehydration
  • fluid and electrolyte deficiency
View approved original text

This medication is used to replenish body fluids and electrolytes during dehydration or before and after surgery. It also provides the necessary energy to aid in recovery.

How it is given

Adult administration

The usual dose for adults is 500~1,000mL per dose by intravenous drip infusion. The infusion rate is 300~500mL per hour (75~120 drops per minute). Adjust the dose and infusion rate as appropriate according to age, body weight, and symptoms.

Child administration

For children, administer at a rate of 50~100mL per hour. Do not administer rapidly (at a rate of 100mL or more per hour), especially to newborns and premature infants.

Precautions

This drug contains glucose in intravenous injections, which may significantly increase the consumption of vitamin B1. Therefore, caution is needed as the risk of vitamin B1 deficiency can become serious. It is safer not to use this drug in patients with excessive fluid, storage-type dehydration, and low potassium levels in the blood. It should be administered cautiously to patients with decreased kidney function, weak heart function, severe dehydration, patients who have difficulty urinating due to urinary obstruction, diabetic patients, and those with high levels of chloride in the blood. Rapid or large volume administration of the drug can lead to side effects such as edema in the brain or lungs, swelling of the body, and acidification of the blood. Caution is especially needed when administering rapidly to newborns or premature infants due to the potential for excessive body fluid. There is also a possibility of thrombosis at the site of intravenous injection, so monitoring is necessary. During the use of this medication, blood glucose, blood electrolyte levels, and body fluid balance should be regularly checked to effectively manage health status. In special groups such as pregnant or breastfeeding women, children, and the elderly, the safety of the drug has not been fully established, so it should be used cautiously under medical judgment, particularly considering the impact on the health of the fetus and mother during pregnancy. Newborns and especially premature infants are at high risk of hypoglycemia or hyperglycemia due to difficulty in blood sugar regulation, requiring careful monitoring. Hypoglycemia can cause brain damage or seizures, while hyperglycemia can lead to various complications. Rapid or prolonged administration can be risky for infants and the elderly, so it should be administered slowly at an appropriate rate. In the case of overdose, treatment to manage body fluid levels using diuretics may be necessary. Before administration, skin and instruments should be thoroughly disinfected to prevent infection, and in cold weather, the solution should be warmed to body temperature before use. Any remaining drug after opening should be discarded immediately. During administration, IV injection should be done slowly, and care should be taken to prevent air from entering the bloodstream from the injection container. Continuous use of connected containers may pose risks.

Side effects

  • Cerebral edema
  • pulmonary edema
  • peripheral edema
  • acidosis
  • water intoxication
  • thrombosis

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to prevent air or moisture from entering. This will help maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

A colorless, transparent liquid contained in a polypropylene, multi-layer film plastic container.

Package unit

500 milliliters/bag, 1000 milliliters/bag

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.